Kayne Anderson Rudnick Investment Management
FLNA

Kayne Anderson Rudnick Investment Management’s Filana Therapeutics FLNA Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,000
Closed -$21K – 616
2020
Q1 		$21K Buy
+5,000
New +$33.1K ﹤0.01% 423

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's FLNA Position: Q2 2020 in Review

Kayne Anderson Rudnick Investment Management sold out of Filana Therapeutics (FLNA) in Q2 2020, closing a stake of 5,000 shares — an estimated $21K sold.

Kayne Anderson Rudnick Investment Management first reported a position in FLNA in Q1 2020 and held it in 1 quarter. The position peaked at $21K in Q1 2020. 51 funds tracked by Wall St. Rank hold FLNA as of Q2 2020.

  • Kayne Anderson Rudnick Investment Management reported no remaining Filana Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 5,000 Filana Therapeutics shares in Q2 2020, an estimated $21K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Filana Therapeutics in Q1 2020 and held it in 1 quarter.
  • Kayne Anderson Rudnick Investment Management's Filana Therapeutics position peaked at $21K in Q1 2020.
  • 51 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2020.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.